Table of Contents Author Guidelines Submit a Manuscript
Infectious Diseases in Obstetrics and Gynecology
Volume 2013 (2013), Article ID 784718, 8 pages
http://dx.doi.org/10.1155/2013/784718
Research Article

Effect of Highly Active Antiretroviral Therapy (HAART) and Menopause on Risk of Progression of Cervical Dysplasia in Human Immune-Deficiency Virus- (HIV-) Infected Women

1Division of Infectious Diseases, Department of Medicine, University of Rochester Medical Center, P.O. Box 689 601, Elmwood Avenue, Rochester, NY 14642, USA
2Department of Biostatistics and Computational Biology, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA
3Division of Geriatrics and Aging, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA

Received 15 July 2013; Revised 30 October 2013; Accepted 3 November 2013

Academic Editor: Ann Duerr

Copyright © 2013 Suk Chul Kim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. A. Engels, R. J. Biggar, H. I. Hall et al., “Cancer risk in people infected with human immunodeficiency virus in the United States,” International Journal of Cancer, vol. 123, no. 1, pp. 187–194, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. M. C. Delmas, C. Larsen, B. van Benthem et al., “Cervical squamous intraepithelial lesions in HIV-infected women: prevalence, incidence and regression,” AIDS, vol. 14, no. 12, pp. 1775–1784, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Kadhel, L. Multigner, F. Bardinet, M. T. Goerger-Sow, and E. Janky, “Cervical intraepithelial neoplasia and invasive cancer risks in women infected with HIV in the French West Indies,” HIV Medicine, vol. 13, no. 1, pp. 79–82, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. T. V. Ellerbrock, M. A. Chiasson, T. J. Bush et al., “Incidence of cervical squamous intraepithelial lesions in HIV-infected women,” Journal of the American Medical Association, vol. 283, no. 8, pp. 1031–1037, 2000. View at Google Scholar · View at Scopus
  5. H. Minkoff, L. Ahdieh, L. S. Massad et al., “The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women,” AIDS, vol. 15, no. 16, pp. 2157–2164, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Ahdieh-Grant, R. Li, A. M. Levine et al., “Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women,” Journal of the National Cancer Institute, vol. 96, no. 14, pp. 1070–1076, 2004. View at Google Scholar · View at Scopus
  7. D. H. Adler, L. Kakinami, T. Modisenyane et al., “Increased regression and decreased incidence of HPV-related cervical lesions among HIV-infected women on HAART,” AIDS, vol. 26, no. 13, pp. 1645–1652, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. I. Heard, J.-M. Tassie, M. D. Kazatchkine, and G. Orth, “Highly active antiretroviral therapy enhances regression of cervical intraepithelial neoplasia in HIV-seropositive women,” AIDS, vol. 16, no. 13, pp. 1799–1802, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Schuman, S. E. Ohmit, R. S. Klein et al., “Longitudinal study of cervical squamous intraepithelial lesions in Human Immunodefidency Virus (HIV)-seropositive and at-risk HIV-seronegative women,” The Journal of Infectious Diseases, vol. 188, no. 1, pp. 128–136, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. F. B. Lillo, D. Ferrari, F. Veglia et al., “Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy,” The Journal of Infectious Diseases, vol. 184, no. 5, pp. 547–551, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Blitz, J. Baxter, J. Raboud et al., “Evaluation of HIV and highly active antiretroviral therapy on the natural history of human papillomavirus infection and cervical cytopathologic findings in HIV-positive and high-risk HIV-negative women,” The Journal of Infectious Diseases, vol. 208, no. 3, pp. 454–462, 2013. View at Google Scholar
  12. C. Firnhaber, D. Westreich, D. Schulze et al., “Highly active antiretroviral therapy and cervical dysplasia in HIV-positive women in South Africa,” Journal of the International AIDS Society, vol. 15, no. 2, article 17382, 2012. View at Google Scholar
  13. ACOG Committee on Practice Bulletins—Gynecology, “ACOG practice bulletin no. 109: cervical cytology screening,” Obstetrics and Gynecology, vol. 114, no. 6, pp. 1409–1420, 2009. View at Google Scholar
  14. R. Bernstein, D. Dejoseph, and E. M. Buchanan, “When to stop screening: a review of breast, gynecologic, and colorectal cancer screening in women over age 65,” Care Management Journals, vol. 11, no. 1, pp. 48–57, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Kanapathipillai, M. Hickey, and M. Giles, “Human immunodeficiency virus and menopause,” Menopause, vol. 20, no. 9, pp. 983–990, 2013. View at Google Scholar
  16. S. D. Harlow, M. Gass, J. E. Hall et al., “Executive summary of the stages of reproductive aging workshop + 10: addressing the unfinished agenda of staging reproductive aging,” Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 4, pp. 1159–1168, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. “The 1988 Bethesda system for reporting cervical/vaginal cytological diagnoses. National Cancer Institute Workshop,” The Journal of the American Medical Association, vol. 262, no. 7, pp. 931–934, 1989.
  18. D. Solomon, D. Davey, R. Kurman et al., “The 2001 bethesda system: terminology for reporting results of cervical cytology,” The Journal of the American Medical Association, vol. 287, no. 16, pp. 2114–2119, 2002. View at Google Scholar · View at Scopus
  19. R. M. Baron and D. A. Kenny, “The moderator-mediator variable distinction in social psychological research. Conceptual, strategic, and statistical considerations,” Journal of Personality and Social Psychology, vol. 51, no. 6, pp. 1173–1182, 1986. View at Publisher · View at Google Scholar · View at Scopus
  20. D. H. Adler, “The impact of HAART on HPV-related cervical disease,” Current HIV research, vol. 8, no. 7, pp. 493–497, 2010. View at Google Scholar · View at Scopus
  21. G. Sirera, S. Videla, R. López-Blázquez et al., “Highly active antiretroviral therapy and incidence of cervical squamous intraepithelial lesions among HIV-infected women with normal cytology and CD4 counts above 350 cells/mm3,” Journal of Antimicrobial Chemotherapy, vol. 61, no. 1, pp. 191–194, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. “Panel on antiretroviral guidelines for adults and adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents,” Department of Health and Human Services, 2011, http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf.
  23. A. L. Moore, C. A. Sabin, S. Madge, A. Mocroft, W. Reid, and M. A. Johnson, “Highly active antiretroviral therapy and cervical intraepithelial neoplasia,” AIDS, vol. 16, no. 6, pp. 927–929, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Palefsky, “Biology of HPV in HIV infection,” Advances in Dental Research, vol. 19, no. 1, pp. 99–105, 2006. View at Google Scholar · View at Scopus
  25. P. F. Ceccaldi, C. Ferreira, F. Coussy et al., “Cervical disease in postmenopausal HIV-1-infected women,” Journal de Gynécologie, Obstétrique et Biologie de la Reproduction, vol. 39, no. 6, pp. 466–470, 2010. View at Google Scholar
  26. L. S. Massad, C. T. Evans, H. Minkoff et al., “Effects of HIV infection and its treatment on self-reported menstrual abnormalities in women,” Journal of Women's Health, vol. 15, no. 5, pp. 591–598, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. E. E. Schoenbaum, D. Hartel, Y. Lo et al., “HIV infection, drug use, and onset of natural menopause,” Clinical Infectious Diseases, vol. 41, no. 10, pp. 1517–1524, 2005. View at Google Scholar
  28. A. C. Rodriguez, M. Schiffman, R. Herrero et al., “Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection,” Journal of the National Cancer Institute, vol. 102, no. 5, pp. 315–324, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Ansari, G. Mehdi, S. H. Arif, H. Ansari, and T. Khan, “Smear patterns and spectrum of premalignant and malignant cervical epithelial lesions in postmenopausal Indian women: a hospital-based study,” Diagnostic Cytopathology, vol. 40, no. 11, pp. 976–983, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. K. N. Moore, R. J. Bannon, G. S. Lanneau, R. E. Zuna, J. L. Walker, and M. A. Gold, “Cervical dysplasia among women over 35 years of age,” American Journal of Obstetrics and Gynecology, vol. 199, no. 5, pp. 471.e1–471.e5, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. Centers for Disease Control and Prevention, “Cervical cancer,” 2010, http://www.cdc.gov/Cancer/Cervical.